Dr. Joseph Henry Tieri D.O.

Recommended Articles

• Health Care Reform in Washington Affects Parkinson's Disease Patients

  Lately, and especially during these last 150 days, there has been a predominant debate in the Congress. The controversy around the debate begins with the potentially negative impact this new legislation may be covering. Community affected by this decision have already made their opinion public,...

• Muscular Dystrophy: Representing Rare Diseases and the Problem of Unaffordable Therapies

  It’s called a rare disease any kind of condition that affects a number that is less than or equal to 200,000 Americans. Rare diseases are commonly over-looked by the community because not much people suffer from them, but most of the symptoms and signals said diseases cause will leave a surprised...

• Blocking Enzymes May Be the Key to Alzheimer's Treatment

  Scientists at the Massachusetts Institute of Technology (MIT) have been working on a potential new treatment for Alzheimer’s disease. They are honing in on the genetics involved, hoping to hijack enzymes to do the job.There are genes that turn on to help us make new memories.It’s been shown in...

• What are the Different Stages of Alzheimer's Disease?

  The symptoms of Alzheimer’s disease are seen years after the start of the disease, until the person remains ignorant about the presence of the condition. Symptoms begin to appear as the damage to brain cells increases with progress of the disease. The disease often passes through three stages –...

• An Innovation in Alzheimer's That Is Still Under Used

  In November 2017, Bill Gates announced his significant investment of 100 million USD to support the efforts in finding the drugs that could help to understand Alzheimer’s disease. Gates pointed out that this investment would help to fund the analysis of the massive amounts of data that has been...

• Diabetes Drug May Help Prevent Parkinson's, Study Shows

  Drugs used to treat type 2 diabetes, belonging to a class called glitazones (GTZs) may reduce the risk of Parkinson’s by as much as 28 percent, a study suggests. It was a large scale study done by analyzing more than 100 million prescriptions. ...